Brief: Boiron Enters Into Exclusive Negotiations To Acquire Hivital Labs
01/10/2026 10:34
BRIEF-Boiron Enters Into Exclusive Negotiations To Acquire Hivital Labs Oct 1 (Reuters) - Boiron SA BOIR.PA:
BOIRON LABORATORIES ARE ENTERING INTO EXCLUSIVE NEGOTIATIONS WITH A VIEW TO ACQUIRING HIVITAL LABS
FINAL AGREEMENTS COULD BE SIGNED DURING Q4 OF 2026
HIVITAL LABS SPECIALISES IN DEVELOPMENT AND ONLINE SALE OF DIETARY SUPPLEMENTS AND ACHIEVED A TURNOVER OF OVER €10 MILLION IN 2025
Source text: ID: nACT100593
Further company coverage: BOIR.PA
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00; ))
Recent news on Boiron SA
See all newsBrief: Boiron Enters Into Exclusive Negotiations To Acquire Hivital Labs
Brief: Boiron FY Revenue EUR 501.11 Mln, Proposes Dividend Of EUR 1.35 Per Share
Brief: Boiron Signs Agreement With Panaxia Malta For Research And Development Of Cannabis For Medical Use
Brief: Thierry Boiron Steps Down As Deputy CEO Of Boiron SA
Brief: Boiron H1 Net Income Group Part EUR 11.4 Mln